AgenDx Biosciences Company
AgenDx is an early stage molecular diagnostics company develops a revolutionary cost-effective molecular diagnostics platform.
Industry:
Deep Diagnostics
Technology:
Genetic Test & Molecular Diagnostics
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Investors Number:
2
Headquarters:
South Bend, Indiana, United States
Employee Number:
1-10
Investor Type:
For Profit
Total Funding:
$39.4M
Founded Date:
01.01.2014
Last Funding Type:
Post-IPO Debt